Results of the SAIVE study demonstrating good tolerability as well as statistically significant efficacy of Ivermectin vs placebo in the prevention of post-exposure COVID-19 infection will be communicated by MedinCell on April 18, 2023 at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, Denmark, 15 – 18 April, 2023)
